Dr. Barry Dworkin

Rare cases of possible Alzheimer’s transmission uncovered in recipients of discontinued cadaver-based growth hormone treatments

Medical Mythbusting Commentary for January 31, 2024

Source:
Rare cases of possible Alzheimer’s transmission uncovered in recipients of discontinued medical treatment

Reference:
Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

Related posts:

  1. Do not hang your hat on an unapproved Alzheimer’s blood test.
  2. End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.
  3. Discovery could explain why women are more likely to get Alzheimer’s
  4. Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.